Dr. Wolf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1440 E County Line Rd
Indianapolis, IN 46227Phone+1 317-497-2760Fax+1 317-887-4685- Is this information wrong?
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Obstetrics and Gynecology, 1986 - 1990
- Northeast Ohio Medical UniversityClass of 1986
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology
Certifications & Licensure
- IN State Medical License 2014 - 2025
- WI State Medical License 2019 - 2025
- MT State Medical License 2023 - 2025
- GA State Medical License 2014 - 2024
- PA State Medical License 2022 - 2024
- MN State Medical License 1990 - 2024
- AZ State Medical License 2011 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Clinical Trials
- Gene Therapy in Treating Patients With Ovarian Cancer Start of enrollment: 1998 Sep 01
- PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2002 Jul 01
- Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2004 Sep 02
- Join now to see all
Publications & Presentations
PubMed
- Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma.Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt, Erik S. Leshane, Jyotsna B. Halder, Guillermo N. Armaiz-Pena, Whitney A. Spannuth, Takemi Tanaka, Mian M.K. Sha...> ;Clinical Cancer Research. 2021 Aug 1
- 2 citationsPhase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancerAnca Chelariu-Raicu, Charles F Levenback, Brian M. Slomovitz, Judith K. Wolf, Diane C. Bodurka, John J. Kavanagh, Christopher Morrison, David M. Gershenson, Robert L. ...> ;International Journal of Gynecological Cancer. 2020 Oct 9
- 2 citationsPhase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.Brian M. Slomovitz, Anca Chelariu-Raicu, Kathleen M. Schmeler, Karen H. Lu, David M. Gershenson, Judith K. Wolf, Robert L. Coleman> ;International Journal of Gynecological Cancer. 2020 Oct 5
- Join now to see all
Press Mentions
- Provista Diagnostics Appoints Judith K. Wolf, M.D., as Chief Medical OfficerJuly 28th, 2016
Hospital Affiliations
- Community Hospital NorthIndianapolis, Indiana
- Community Hospital SouthIndianapolis, Indiana
- Goshen HealthGoshen, Indiana
- Penn State Milton S. Hershey Medical CenterHershey, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: